Kretschmer V, Weippert-Kretschmer M
Abteilung für Transfusionsmedizin und Hämostaseologie, Universitätskliniken, Marburg, BRD.
Beitr Infusionsther. 1993;31:209-14.
Modern haemotherapy is equivalent to restrictive use of blood components. Therefore, transfusion of whole blood in homologous transfusion generally cannot be accepted. In autologous blood transfusion blood components also are preferable if they can be separated appropriately. In order to have broad application of preoperative autologous blood deposits, close cooperation to transfusion services should be established guaranteeing optimal production of blood components. If this cooperation is impossible there are no objections against the use of autologous whole blood as long as the expected blood consumption is less than 3 red cell units. Additionally, in this case storage of more than 3 weeks mostly is not necessary. The fact that whole blood is not further part of the 'Monographien' of the Federal Health Administration (BGA) does not forbid the use of autologous whole blood since the 'Monographien' only concern generally available homologous blood components.
现代血液疗法等同于对血液成分的限制性使用。因此,同源输血中一般不接受输注全血。在自体输血中,如果能够适当分离,血液成分也是更可取的。为了使术前自体血储存得到广泛应用,应与输血服务部门密切合作,以确保血液成分的最佳制备。如果无法进行这种合作,只要预期的血液消耗量少于3个红细胞单位,就不反对使用自体全血。此外,在这种情况下,大多无需储存超过3周。全血不再是联邦卫生局(BGA)“专著”的一部分,这一事实并不禁止使用自体全血,因为“专著”仅涉及一般可获得的同源血液成分。